GHTF (Global Harmonisation Task Force) has new Japanese chair:
This article was originally published in Clinica
Executive Summary
The director of the Medical Devices Evaluation Office at the Japanese Ministry of Health, Labor and Welfare, Taisuke Hojo, has becomes the latest chair of the Global Harmonisation Task Force. He takes over from Souichi Ikegaya, director of evaluation and licensing at the ministry, who retired on August 30 and is therefore no longer in a position to chair the GHTF. Mr Ikegaya had only taken over from the Australian chair, Rita Maclachlan on July 1. Dr Hojo will chair the fifth meeting of the GHTF Steering Committee on October 28-30.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.